DLBCL

Cecilia BrownAggressive B-Cell Lymphoma | November 22, 2022
A new model that makes use of a promising imaging biomarker can predict diffuse large B-cell lymphoma relapse and survival ...
Sabrina AhleAggressive B-Cell Lymphoma | November 14, 2022
The U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to nanatinostat and valganciclovir for the ...
Advertisement
Advertisement
Advertisement
Advertisement